Clinical Trials List
Protocol NumberSRF201/SRF201-B
2024-09-01 - 2027-12-31
Phase II
Recruiting2
ICD-10M34.0
Progressive systemic sclerosis
ICD-10M34.1
CR(E)ST syndrome
ICD-10M34.2
Systemic sclerosis induced by drug and chemical
ICD-10M34.89
Other systemic sclerosis
ICD-10M34.9
Systemic sclerosis, unspecified
ICD-9710.1
Systemic sclerosis
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 謝祖怡 Division of Rheumatology
- 譚國棟 Division of Rheumatology
- 顏在弘 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- 賴國隆 Division of Rheumatology
- 廖育婉 Division of Rheumatology
- 曾智偉 Division of Rheumatology
- HSIN-HUA CHEN Division of Rheumatology
- 林靖才 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- 高宗楙 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
200 participants
